https://www.live-feeds.com/feed/walmart-settles-us-government-s-opioid-lawsuitContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/walmart-settles-us-government-s-opioid-lawsuithttps://www.live-feeds.com/feed/walmart-settles-us-government-s-opioid-lawsuit#u53009Mon, 31 Aug 2026 10:25:44 +0000Walmart agreed to pay $50 million to resolve a Department of Justice and Drug Enforcement Administration lawsuit alleging the company filled thousands of prescriptions for opioids and other controlled substances without legitimate medical purposes. The federal government claimed Walmart violated the Controlled Substances Act starting in June 2013. While Walmart pharmacists flagged suspicious orders and filed refusal-to-fill forms, prosecutors argued the company's compliance structure failed to act on those warnings. The settlement ends a legal battle that began with a 2020 federal filing https://www.live-feeds.com/feed/walmart-settles-us-government-s-opioid-lawsuithttps://www.live-feeds.com/feed/walmart-settles-us-government-s-opioid-lawsuit#u51966Sun, 30 Aug 2026 04:16:21 +0000Walmart has agreed to pay $50 million to settle a US government lawsuit alleging its pharmacies filled thousands of invalid prescriptions for opioids and other controlled substances since 2013. The settlement includes a new DEA compliance framework with specific reporting and monitoring requirements. This resolves allegations from the Justice Department and DEA.Why it mattersThe lawsuit, filed in 2020, accused Walmart of fueling the nationwide opioid epidemic by unlawfully dispensing prescriptions from its pharmacies. The settlement removes a significant legal overhang for the company. Walmart https://www.live-feeds.com/feed/walmart-settles-us-government-s-opioid-lawsuithttps://www.live-feeds.com/feed/walmart-settles-us-government-s-opioid-lawsuit#u51787Sat, 29 Aug 2026 13:05:43 +0000Walmart has agreed to settle a U.S. government lawsuit regarding the unlawful dispensing of opioids and other controlled substances. The company will pay $50 million to resolve allegations from the Justice Department and DEA that its pharmacies filled thousands of invalid prescriptions since 2013. As part of the agreement, Walmart must adhere to a new DEA compliance framework that mandates specific reporting and monitoring requirements. The settlement removes a legal overhang that had affected the company since the Justice Department first filed the suit in 2020.Why it mattersThe Justice Depar